Authors: DOWSETT M DETRE S ORMEROD MG ELLIS PA MAINWARING PN TITLEY JC SMITH IE

Citation: M. Dowsett et al., ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS, Cytometry, 32(4), 1998, pp. 291-300

Authors: MAINWARING PN ELLIS PA DETRE S SMITH IE DOWSETT M

Citation: Pn. Mainwaring et al., COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER, Journal of Clinical Pathology, 51(1), 1998, pp. 34-37

Authors: MAINWARING PN ATKINSON H CHANG J MOORE J HANCOCK BW GUILLOU PJ OSKAM R GORE ME

Citation: Pn. Mainwaring et al., DIFFERENTIAL RESPONSES TO CHEMOIMMUNOTHERAPY IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, European journal of cancer, 33(9), 1997, pp. 1388-1392

Authors: MAINWARING PN NICOLSON MC HICKISH T PENSON R JOEL S SLEVIN M SMITH IE

Citation: Pn. Mainwaring et al., CONTINUOUS INFUSIONAL TOPOTECAN IN ADVANCED BREAST AND NON-SMALL-CELLLUNG-CANCER - NO EVIDENCE OF INCREASED EFFICACY, British Journal of Cancer, 76(12), 1997, pp. 1636-1639

Authors: MAINWARING PN GORE ME

Citation: Pn. Mainwaring et Me. Gore, THE IMPORTANCE OF DOSE AND SCHEDULE IN CANCER-CHEMOTHERAPY - EPITHELIAL OVARIAN-CANCER, Anti-cancer drugs, 6, 1995, pp. 29-41

Authors: CHILDS AM COATES AS COX KM MAINWARING PN

Citation: Am. Childs et al., SEVERE VASCULAR ADVERSE-EFFECTS WITH THROMBOCYTOPENIA AND RENAL-FAILURE FOLLOWING EMETOGENIC CHEMOTHERAPY AND ONDANSETRON, Annals of oncology, 5(1), 1994, pp. 98-98